Sex and gender differences in kidney cancer: clinical and experimental evidence

AJ Peired, R Campi, ML Angelotti, G Antonelli, C Conte… - Cancers, 2021 - mdpi.com
Simple Summary Kidney cancer is a frequent malignant tumor that accounts for
approximately 5% of all cancer incidences. It affects both males and females, but males are …

Beyond prostate cancer: An androgen receptor splice variant expression in multiple malignancies, non-cancer pathologies, and development

KD Katleba, PM Ghosh, M Mudryj - Biomedicines, 2023 - mdpi.com
Multiple studies have demonstrated the importance of androgen receptor (AR) splice
variants (SVs) in the progression of prostate cancer to the castration-resistant phenotype …

The influence of sex hormones on renal cell carcinoma

M Ladurner, AK Lindner, P Rehder… - … Advances in Medical …, 2024 - journals.sagepub.com
Kidney cancer is a common malignancy that constitutes around 5% of all cancer cases.
Males are twice as likely to acquire renal cell carcinoma (RCC) compared to females and …

Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors

S Pak, W Kim, Y Kim, C Song, H Ahn - Journal of cancer research and …, 2019 - Springer
Abstract Purpose Androgen receptors (ARs) are expressed on a variety of cell types, and AR
signaling plays an important role in tumor development and progression in several cancers …

Association of sex hormones with risk of cancers of the pancreas, kidney, and brain in the UK biobank cohort study

R Peila, RS Arthur, TE Rohan - Cancer Epidemiology, Biomarkers & …, 2020 - AACR
Background: There is some evidence to suggest that endogenous levels of sex hormones
might influence the etiology of cancers of the pancreas, kidney, and brain, but epidemiologic …

The genomic landscape of pediatric renal cell carcinomas

P Beck, B Selle, L Madenach, DTW Jones, C Vokuhl… - Iscience, 2022 - cell.com
Pediatric renal cell carcinomas (RCC) differ from their adult counterparts not only in
histologic subtypes but also in clinical characteristics and outcome. However, the underlying …

Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti …

P Popławski, JR Wiśniewski, E Rijntjes, K Richards… - PLoS …, 2017 - journals.plos.org
Type 1 iodothyronine deiodinase (DIO1) contributes to deiodination of 3, 5, 3', 5'-tetraiodo-L-
thyronine (thyroxine, T4) yielding of 3, 5, 3'-triiodothyronine (T3), a powerful regulator of cell …

[HTML][HTML] Abiraterone and Galeterone, Powerful Tools Against Prostate Cancer: Present and Perspective

IZ Kuzminac, AR Nikolić, MP Savić… - …, 2024 - pmc.ncbi.nlm.nih.gov
Due to the high prostate cancer incidence worldwide, the development of different methods
of treatment continues to be a hot research topic. Since its first clinical application at the …

Retrospective study assessing the role of the androgen receptor in clear cell renal cell cancer patients treated with VEGFR inhibitors in monotherapy

L Osorio, TP Grazioso, G de Velasco, O Etxaniz… - Clinical and …, 2024 - Springer
Background and purpose Despite that incorporating antiangiogenic in combination with
immune-checkpoint inhibitors as the standard first-line treatment for advanced clear cell …

Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical In Vivo Models

UH Weidle, A Nopora - Cancer Genomics & Proteomics, 2021 - cgp.iiarjournals.org
In order to identify new targets and treatment modalities for clear cell renal carcinoma, we
surveyed the literature with respect to microRNAs involved in this disease. In this review, we …